Monopar Therapeutics Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Monopar Therapeutics quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Monopar Therapeutics Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 3.52M shares, a 24.7% increase year-over-year.
  • Monopar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 13.8M shares, a 8.7% increase from 2022.
  • Monopar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.7M shares, a 1.98% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.